The dopaminergic D1 receptor modulates the hyperactivity of Bapa mutant mice.
Apomorphine, SCH-23,390
Dopamine
Open-field behavior
Stereotypy
Sulpiride
Journal
Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872
Informations de publication
Date de publication:
24 08 2023
24 08 2023
Historique:
received:
27
02
2023
revised:
19
06
2023
accepted:
29
06
2023
medline:
14
8
2023
pubmed:
3
7
2023
entrez:
2
7
2023
Statut:
ppublish
Résumé
The mutant bate-palmas ("claps"; symbol - bapa) mice induced by the mutagenic chemical ENU present motor incoordination and postural alterations. A previous study showed that bapa mice present increased motor/exploratory behaviors during the prepubertal period due to increased striatal tyrosine hydroxylase expression, suggesting striatal dopaminergic system hyperactivity. This study aimed to evaluate the involvement of striatal dopaminergic receptors in the hyperactivity of bapa mice. Male bapa mice and their wild strain (WT) were used. Spontaneous motor behavior was observed in the open-field test, and stereotypy was evaluated after apomorphine administration. The effects of DR1 and DR2 dopaminergic antagonists (SCH-23,390; sulpiride) and the striatal DR1 and D2 receptor gene expression were evaluated. Relative to WT, bapa mice showed: 1) increased general activity for four days; 2) increased rearing and sniffing behavior and decreased immobility after apomorphine; 3) blockage of rearing behavior after the DR2 antagonist but no effect after DR1 antagonist; 4) blockage of sniffing behavior after the DR1 antagonist in bapa and WT mice but no effect after the DR2 antagonist; 5) increased immobility after the DR1 antagonist but no effect after the DR2 antagonist; 6) increased expression of striatal DR1 receptor gene and reduced the DR2 expression gene after apomorphine administration. Bapa mice showed increased activity in open field behavior. The increased rearing behavior induced by apomorphine of bapa mice resulted from the increased gene expression of the DR1 receptor.
Identifiants
pubmed: 37394124
pii: S0166-4328(23)00280-2
doi: 10.1016/j.bbr.2023.114562
pii:
doi:
Substances chimiques
Apomorphine
N21FAR7B4S
Benzazepines
0
Dopamine
VTD58H1Z2X
Dopamine Antagonists
0
Receptors, Dopamine D1
0
Sulpiride
7MNE9M8287
down-regulator of transcription 1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114562Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest Statement The authors declare no conflict of interest.